ABSTRACT
Age-related macular degeneration (AMD) is a leading cause of blindness. The main risk factor is advancing age, with the severity of vision loss ranging from mild to severe. There is a 25% risk of early AMD and 8% risk of late AMD in patients over the age of 75, with the number of cases expected to increase because of the aging population. Diagnosis of the disease requires a dilated fundus examination. Physicians should be aware of the symptoms, risk factors, and treatment options for AMD to refer appropriately for ophthalmologic evaluation. Early detection can be helpful to prevent disease progression.
Subject(s)
Macular Degeneration , Blindness/etiology , Blindness/therapy , Humans , Macular Degeneration/diagnosis , Macular Degeneration/epidemiology , Macular Degeneration/physiopathology , Macular Degeneration/therapy , Risk Factors , Sensory Aids , Vision, Low/etiology , Vision, Low/therapyABSTRACT
Program development and review are a central part of institutional and industry quality assurance. Traditional approaches, although well established, present several barriers that could undermine the integrity of the process and the quality of outcomes. Here, a new approach to program development and design is explored with the goal of enhancing outcomes for students and institutions.
